Health technology assessment and its role in the future development of the Indian healthcare sector

por Hass, Bastian, Pooley, Jayne, Feuring, Martin, Suvarna, Viraj, Harrington, Adrian E.
Publicado 2012

Treatment of venous thromboembolism – effects of different therapeutic strategies on bleeding and recurrence rates and considerations for future anticoagulant management

por Hass, Bastian, Pooley, Jayne, Harrington, Adrian E, Clemens, Andreas, Feuring, Martin
Publicado 2012

Type of anaesthesia and the safety and efficacy of thromboprophylaxis with enoxaparin or dabigatran etexilate in major orthopaedic surgery: pooled analysis of three randomized cont...

por Rosencher, Nadia, Noack, Herbert, Feuring, Martin, Clemens, Andreas, Friedman, Richard J, Eriksson, Bengt I
Publicado 2012

Safety and efficacy of switching from low molecular weight heparin to dabigatran in patients undergoing elective total hip or knee replacement surgery

por Wurnig, Christian, Clemens, Andreas, Rauscher, Helmuth, Kleine, Eva, Feuring, Martin, Windhager, Reinhard, Grohs, Josef
Publicado 2015

Switching from enoxaparin to dabigatran etexilate: pharmacokinetics, pharmacodynamics, and safety profile

por Clemens, Andreas, van Ryn, Joanne, Sennewald, Regina, Yamamura, Norio, Stangier, Joachim, Feuring, Martin, Härtter, Sebastian
Publicado 2012

Dabigatran etexilate for thromboprophylaxis in over 5000 hip or knee replacement patients in a real-world clinical setting

por Rosencher, Nadia, Samama, Charles M., Feuring, Martin, Brueckmann, Martina, Kleine, Eva, Clemens, Andreas, Frostick, Simon
Publicado 2016

Net clinical benefit of dabigatran vs. warfarin in venous thromboembolism: analyses from RE-COVER(®), RE-COVER™ II, and RE-MEDY™

por Feuring, Martin, Schulman, Sam, Eriksson, Henry, Kakkar, Ajay J., Schellong, Sebastian, Hantel, Stefan, Schueler, Elke, Kreuzer, Jörg, Goldhaber, Samuel Z.
Publicado 2017

Oral dabigatran etexilate versus enoxaparin for venous thromboembolism prevention after total hip arthroplasty: pooled analysis of two phase 3 randomized trials

por Eriksson, Bengt I., Dahl, Ola E., Rosencher, Nadia, Clemens, Andreas, Hantel, Stefan, Feuring, Martin, Kreuzer, Jörg, Huo, Michael, Friedman, Richard J.
Publicado 2015